Masters Pharmaceutical, Inc.
Masters Pharmaceutical, Inc., commonly referred to as MastersRx, is a leading player in the pharmaceutical industry, headquartered in the United States. Founded in 2003, the company has established a strong presence in key operational regions across North America, focusing on the development and distribution of high-quality pharmaceutical products. Specialising in generic and specialty medications, MastersRx is recognised for its commitment to innovation and quality assurance. The company’s core offerings include a diverse range of prescription medications that cater to various therapeutic areas, setting them apart through rigorous testing and compliance with industry standards. With a reputation for reliability and excellence, Masters Pharmaceutical has achieved significant milestones, positioning itself as a trusted partner in healthcare. Their dedication to improving patient outcomes and enhancing access to essential medications underscores their notable achievements in the competitive pharmaceutical landscape.
DitchCarbon Score
How does Masters Pharmaceutical, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Masters Pharmaceutical, Inc.'s score of 13 is higher than 80% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Masters Pharmaceutical, Inc.'s reported carbon emissions
Masters Pharmaceutical, Inc., headquartered in the US, currently does not have available carbon emissions data for the most recent year, nor do they have specified reduction targets or climate pledges. In the absence of specific emissions figures, it is important to note that the pharmaceutical industry is increasingly focusing on sustainability and reducing carbon footprints. Companies in this sector are often encouraged to adopt science-based targets and implement initiatives aimed at minimising their environmental impact. While Masters Pharmaceutical, Inc. has not publicly disclosed its commitments or achievements in this area, the industry as a whole is moving towards greater transparency and accountability regarding climate action.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Masters Pharmaceutical, Inc. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
